the beauty of their platform is that their tech can be used for so, so many potential drugs so we are no reliant on getting one deal and that is it. they can sign deal after deal
"Don't worry about the world coming to an end today. It's already tomorrow in Australia"
Recent DYAI News
- Dyadic to Participate in the Lytham Partners Spring 2026 Investor Conference on May 28, 2026 • GlobeNewswire Inc. • 05/21/2026 08:05:00 PM
- Sidoti Events, LLC's May Micro-Cap Virtual Conference • ACCESS Newswire • 05/20/2026 11:30:00 AM
- Dyadic Applied BioSolutions Announces Participation in Sidoti Virtual Investor Conference • GlobeNewswire Inc. • 05/19/2026 01:35:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/13/2026 08:11:27 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/13/2026 08:10:46 PM
- Dyadic Announces First Quarter 2026 Financial Results and Highlights Recent Company Progress • GlobeNewswire Inc. • 05/13/2026 08:05:00 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 05/12/2026 08:30:27 PM
- Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend] • Edgar (US Regulatory) • 05/11/2026 08:42:09 PM
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 05/01/2026 09:00:51 PM
- Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend] • Edgar (US Regulatory) • 04/30/2026 08:00:46 PM
- Dyadic to Report Q1 2026 Financial Results and Host Conference Call on Wednesday May 13, 2026 • GlobeNewswire Inc. • 04/29/2026 08:05:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/28/2026 01:56:17 AM
- Dyadic Announces 2025 Financial Results and Highlights Recent Company Progress • GlobeNewswire Inc. • 03/25/2026 08:51:29 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/25/2026 08:14:00 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 03/25/2026 08:13:15 PM
- Dyadic Applied BioSolutions Announces Commercial Distribution Partnership with IBT Bioservices • GlobeNewswire Inc. • 03/16/2026 11:20:00 AM
- Life Sciences Virtual Investor Forum Presentations Now Available for Online Viewing • GlobeNewswire Inc. • 03/13/2026 12:35:00 PM
- Dyadic to Report 2025 Full Year Financial Results and Host Conference Call on Wednesday, March 25, 2026 • GlobeNewswire Inc. • 03/11/2026 08:10:00 PM
- Life Sciences Virtual Investor Forum Agenda Announced for March 11th & 12th • GlobeNewswire Inc. • 03/10/2026 02:21:44 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/06/2026 10:04:30 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 03/06/2026 10:02:34 PM
- Dyadic and Fermbox Bio Launch First Product Under Expanded Collaboration: Animal-Origin-Free Recombinant DNase I (RNase-Free) • GlobeNewswire Inc. • 03/04/2026 12:20:00 PM
- Dyadic Applied BioSolutions and Inzymes ApS Announce Planned 2026 Commercialization of Non-Animal Dairy Enzyme Following Achievement of Development Milestone • GlobeNewswire Inc. • 03/02/2026 12:20:00 PM
